Endurance Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-290
| Closed | -$25K | – | 630 |
|
|
2020
Q3 | $25K | Sell |
290
-35
| -11% | -$3.02K | ﹤0.01% | 368 |
|
|
2020
Q2 | $28K | Hold |
325
| – | – | ﹤0.01% | 365 |
|
|
2020
Q1 | $27K | Sell |
325
-168
| -34% | -$14K | 0.01% | 340 |
|
|
2019
Q4 | $47K | Buy |
493
+168
| +52% | +$16K | 0.01% | 288 |
|
|
2019
Q3 | $28K | Sell |
325
-8,000
| -96% | -$689K | ﹤0.01% | 329 |
|
|
2019
Q2 | $760K | Buy |
8,325
+7,962
| +2,193% | +$727K | 0.12% | 109 |
|
|
2019
Q1 | $31K | Sell |
363
-4,464
| -92% | -$381K | 0.01% | 300 |
|
|
2018
Q4 | $371K | Buy |
4,827
+4,788
| +12,277% | +$368K | 0.07% | 136 |
|
|
2018
Q3 | $3K | Hold |
39
| – | – | ﹤0.01% | 447 |
|
|
2018
Q2 | $3K | Sell |
39
-1,283
| -97% | -$98.7K | ﹤0.01% | 457 |
|
|
2018
Q1 | $96K | Hold |
1,322
| – | – | 0.02% | 226 |
|
|
2017
Q4 | $99K | Hold |
1,322
| – | – | 0.02% | 218 |
|
|
2017
Q3 | $102K | Hold |
1,322
| – | – | 0.02% | 217 |
|
|
2017
Q2 | $99K | Hold |
1,322
| – | – | 0.02% | 224 |
|
|
2017
Q1 | $88K | Hold |
1,322
| – | – | 0.02% | 227 |
|
|
2016
Q4 | $86K | Hold |
1,322
| – | – | 0.02% | 229 |
|
|
2016
Q3 | $92K | Hold |
1,322
| – | – | 0.02% | 224 |
|
|
2016
Q2 | $98K | Sell |
1,322
-525
| -28% | -$38.9K | 0.02% | 213 |
|
|
2016
Q1 | $120 | Hold |
1,847
| – | – | 0.02% | 200 |
|
|
2015
Q4 | $142K | Sell |
1,847
-335
| -15% | -$25.8K | 0.03% | 188 |
|
|
2015
Q3 | $181K | Hold |
2,182
| – | – | 0.03% | 174 |
|
|
2015
Q2 | $192K | Sell |
2,182
-1,116
| -34% | -$98.2K | 0.03% | 162 |
|
|
2015
Q1 | $291K | Buy |
+3,298
| New | +$291K | 0.05% | 151 |
|